CN1966035A - Chinese medicinal formulation for treating children's hyperkinetic syndrome - Google Patents
Chinese medicinal formulation for treating children's hyperkinetic syndrome Download PDFInfo
- Publication number
- CN1966035A CN1966035A CNA2006101145450A CN200610114545A CN1966035A CN 1966035 A CN1966035 A CN 1966035A CN A2006101145450 A CNA2006101145450 A CN A2006101145450A CN 200610114545 A CN200610114545 A CN 200610114545A CN 1966035 A CN1966035 A CN 1966035A
- Authority
- CN
- China
- Prior art keywords
- parts
- stir
- chinese medicine
- salt solution
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 title claims description 20
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 title claims description 20
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 10
- 239000003814 drug Substances 0.000 claims description 43
- 239000012266 salt solution Substances 0.000 claims description 22
- 210000000582 semen Anatomy 0.000 claims description 22
- 238000002360 preparation method Methods 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 13
- 241000217407 Margaritifera Species 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 239000006196 drop Substances 0.000 claims description 5
- 229940023488 pill Drugs 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000006189 buccal tablet Substances 0.000 claims description 3
- 229940046011 buccal tablet Drugs 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- -1 suspensoid Substances 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 abstract description 4
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 1
- 240000002943 Elettaria cardamomum Species 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 241001499733 Plantago asiatica Species 0.000 abstract 1
- 241000208966 Polygala Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 210000003056 antler Anatomy 0.000 abstract 1
- 235000005300 cardamomo Nutrition 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 230000001660 hyperkinetic effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 230000000694 effects Effects 0.000 description 22
- 210000004185 liver Anatomy 0.000 description 16
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 230000008451 emotion Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012373 Depressed level of consciousness Diseases 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000002091 Febrile Seizures Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002513 anti-ovulatory effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016284 febrile convulsion Diseases 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 150000003376 silicon Chemical class 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal composition for treating children's hyperkinetic symptom, which is prepared from Chinese medicinal herbs including deglued antler powder, prepared rehmannia root, bitter cardamon, wild jujuba seeds, mother-of-pearl, grassleaved sweetflag rhizome, polygala root, plantago asiatica linne and gentian root.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of hyperkinetic syndrome, is that a kind of hyperkinetic syndrome for the treatment of is the Chinese patent medicine of raw material with the Chinese herbal medicine.Belong to the field of Chinese medicines.
Background technology
Hyperkinetic syndrome is a kind of common children's behavior abnormal problem, claims Cerebral function slight maladjustment or slight dysfunction syndrome or attention deficit hyperactivity disorder again.This class infant intelligence normally or normal substantially, but study, behavior and emotion aspect defectiveness show as difficult concentrating, note of short duration, hyperactivity, emotion is inflammable so that influence school grade.All keep on unpleasant terms with people in family and school, make the head of a family and teacher feel difficulty in the daily life.The foreign data report is ill to be about 5%～10%.Domestic to think that also school age population is sent out the patient quite a lot of, accounts for all pupils 1%～10%.Boy is many than girl, and about 4～9: 1.Send out 6～14 years old age well.Not only influence child's physical and mental health, develop into aggressivity, destructive behavior sometimes.Become the problem of social concerns in recent years.
Chinese medicine thinks that the natural endowment deficiency is the endogenous cause of ill of primary disease, and is in bad health as father and mother, particularly mother's pregnancy period how sick, cause the plain body weakness of children.Lack of proper care after one's birth, maternal infuries or other sick wounds, and educate the improper morbidity that all can cause.The clinical symptoms of hyperkinetic syndrome is: 1, attention deficit disorder: show as absent mindedly, not lasting, disperse easily; It is inwholwe-hearted to listen to the teacher, and can not fulfil assignment on time, is divert one's attention by environmental stimuli easily.2, hyperactivity: show as on the classroom or the quiet heart that do not descend during operation, do not stop twisting on seat, or the class hour of lasting did little trick, desk was cut rubber, or was gazed around fingernail biting, quarter, influenced the classroom order; Just run around here and there after class, brothers do not stop or disorderly dash disorderly and hit.3, impulsion is wilful: show as disposition and suddenly make an uproar, hot-tempered, it is disorderly and unsystematic to do things, and impulsion property, aggression are arranged, and as can not patience waiting, disturbs other people activity; Handling affairs lacks thinking, is regardless of the consequences, even destroys thing, fights, and provokes a dispute.4, behavior change: show as slow movement, operation can not be finished for a long time; Emotion fluctuates easily, being happy and angry uncertainly.5, learning difficulty is the result of hyperkinetic syndrome.To compare following symptom more common with Most of children of the same age, need possess eight in the following behavior.1, usually hands or foot-propelled are individual does not stop or does not stop on seat to twist.Be difficult to sit quietly when 2, wanting it to sit quietly.3, be subjected to environmental stimuli easily and take sb's mind off sth.4, can not wait in line wheel patiently in recreation or collective activity substitutes in.5, usually not intact promptly the robbing of others' question answered.6, be difficult to do thing by others' indication.7, in operation or recreation, be difficult to keep attention to be concentrated.8, usually another part thing is not finished and changed to something.9, be difficult to undisturbedly play.10, often words are many.11, often interrupt or disturb the activity that upsets others, as disturb other children's game.12, others and he when speaking usually like listening non-tin.13, usually be lost in study and the movable article that will use in school or the family.14, usually participate in the adventurous activity of body do not considered the consequence that may cause.Belong to categories such as " restless ", " becoming deaf ", " forgetful " according to clinical manifestation.
The traditional Chinese medical science is divided into disease type determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs such as the liver of suffering from a deficiency of the kidney is high, deficiency of both the heart and spleen, type of phlegm-heat attacking the heart and has received effect preferably.The method of western medical treatment primary disease is a lot, but great majority can only reach recent clinical effectiveness, and can not prevent recurrence, and has toxic and side effects in various degree.
Summary of the invention
The present invention develops in conjunction with the latest modern technological scientific achievement on the basis of traditional tcm syndrome differentiation and treatment.The purpose of this invention is to provide a kind of Chinese medicine preparation for the treatment of hyperkinetic syndrome, and have determined curative effect, safe ready, little, the cheap characteristics of side effect.
The present invention is made by the following weight proportion raw material:
0.5～3.0 part of 1.5～6.0 parts of stir-baked FRUCTUS ALPINIAE OXY-PHYLLAE after sprinking salt solution of 0.1～2.0 part of Radix Rehmanniae Preparata of Cornu Cervi Degelatinatum
1.5～6.0 parts of 0.5～3.0 part of living Concha Margaritiferas of 0.5～3.0 part of Rhizoma Acori Graminei of Semen Ziziphi Spinosae (parched)
0.1～2.0 part of 0.1～2.0 part of wine Radix Gentianae of 0.1～2.0 part of stir-baked SEMEN PLANTAGINIS with salt solution of Radix Polygalae (processed)
The weight proportion of each raw material of optimization formula of the present invention is:
1.0～2.0 parts of 2.5～3.5 parts of stir-baked FRUCTUS ALPINIAE OXY-PHYLLAE after sprinking salt solution of 0.5～1.5 part of Radix Rehmanniae Preparata of Cornu Cervi Degelatinatum
2.5～3.5 parts of 1.0～2.0 parts of living Concha Margaritiferas of 1.0～2.0 parts of Rhizoma Acori Graminei of Semen Ziziphi Spinosae (parched)
0.5～1.5 part of 0.5～1.5 part of wine Radix Gentianae of 0.5～1.5 part of stir-baked SEMEN PLANTAGINIS with salt solution of Radix Polygalae (processed)
The weight proportion of each raw material of optimum formula of the present invention is:
1.5 parts of 3 parts of stir-baked FRUCTUS ALPINIAE OXY-PHYLLAE after sprinking salt solution of 1 part of Radix Rehmanniae Preparata of Cornu Cervi Degelatinatum
3 parts of 1.5 parts of living Concha Margaritiferas of 1.5 parts of Rhizoma Acori Graminei of Semen Ziziphi Spinosae (parched)
1 part of 1 part of wine Radix Gentianae of 1 part of stir-baked SEMEN PLANTAGINIS with salt solution of Radix Polygalae (processed)
Drug action mechanism among the present invention is as follows:
The Cornu Cervi Degelatinatum nature and flavor are salty, temperature.Return liver, kidney channel.Has tonify deficiency, supporing yang effect.Can treat insufficiency of kidney-YANG, ache of the spinal column, Deficiency and coldness of spleen and stomach, vomiting, anorexia and loose stool, deficiency-cold of uterus, bleeding not during menses etc.(" Chinese medicine voluminous dictionary " the 2241st page).
The Radix Rehmanniae Preparata nature and flavor are sweet, cold.GUIXIN, liver, kidney channel.Has clearing away heat and cooling blood, yin nourishing, the effect of promoting the production of body fluid.Can treat that calentura crimson tongue excessive thirst, interior-heat caused by deficiency of YIN, hectic fever due to YIN-deficiency consumptive fever, interior-heat are quenched one's thirst, haematemesis, epistaxis, send out speckle dermexanthesis etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 514th page).
Stir-baked FRUCTUS ALPINIAE OXY-PHYLLAE after sprinking salt solution nature and flavor suffering, temperature.Return spleen, kidney channel.Have warming spleen and stopping diarrha, the effect of warming the kidney controlling nocturnal emission with astringent drugs reducing urination.Can treat that spleen-cold syndrome is had loose bowels, cold type of pain in the abdomen, mouthful slaver over more, enuresis due to deficiency of the kidney, frequent micturition, seminal emission nebulousurine etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 1048th page).
The Semen Ziziphi Spinosae (parched) nature and flavor are sweet, flat.GUIXIN, spleen, liver, gallbladder meridian.Have nourishing the liver, mind calming is calmed the nerves, the effect of arresting sweating.Can treat restlessness of asrhenia type and insomnia, palpitation with fear palpitation with a distress feeling, excessive thirst, sweating due to debility etc.(" Chinese medicine voluminous dictionary " the 2535th page).
It is salty, cold to give birth to the Concha Margaritifera nature and flavor.Return liver, heart channel.Has suppressing the hyperactive liver and subsiding YANG, the effect that arresting convulsion makes eye bright.Can treat that dizziness, tinnitus, cardiopalmus, insomnia, demented, infantile convulsion, haematemesis, epistaxis, metrorrhagia, liver-heat conjunctival congestion, deficiency of the liver blurred vision, irritability, deficiency of the liver are timid, hyperchlorhydria, anovulatory dysfunctional uterine hemorrhage, hemorrhage due to artificial abortion etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 854th page).
Rhizoma Acori Graminei nature and flavor suffering, hardship, temperature.GUIXIN, stomach warp.Have removing dampness appetizing, the eliminating phlegm of having one's ideas straightened out, tranquillizing and allaying excitement, ward off dirty parasite killing, blood pressure lowering, spasmolytic, anti-inflammation, the effect of detoxifying, regulate the flow of vital energy, invigorating blood circulation.Can treat epilepsy, expectorant febrile convulsion, calentura coma, forgetful, deafness with qi stagnation, ambition unhappiness, anemofrigid-damp arthralgia, stomachache, distension and fullness in the abdomen, enteritis, dysentery, chronic bronchitis, infantile pneumonia, sputum obturation, obnubilation, carbuncle tinea scabies, traumatic injury etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 399th page).
Radix Polygalae (processed) nature and flavor hardship, suffering, temperature.GUIXIN, kidney, lung meridian.Have the Fructus Alpiniae Oxyphyllae of calming the nerves, eliminate the phlegm, the repercussive effect.It is swollen etc. to treat phlegm retention, coma, cough, insomnia, palpitation with fear, forgetful, nocturnal emission, carbuncle skin ulcer.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 620th page).
The stir-baked SEMEN PLANTAGINIS with salt solution nature and flavor are sweet, be slightly cold.Return liver, kidney, lung, small intestinal, urinary bladder channel.Has clearing away heat and promoting diuresis, eliminating dampness by diuresis antidiarrheal, liver heat removing and eyesight improving, the effect of removing heat from the lung and dissipating phlegm.Can treat the cough due to lung-heat, urinary system infection, calculus, gastritis edema, dysuria, enteritis, bacillary dysentery, acute icterohepatitisshock, bronchitis, acute eye conjunctivitis, stranguria with turbid discharge, leukorrhagia, hematuria, edema, hematodiarrhoea is had loose bowels, epistaxis, conjunctival congestion and swelling pain, sore throat tonsillitis, cough, skin ulcer etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 291st page).
Wine Radix Gentianae nature and flavor hardship, cold.Return liver, gallbladder meridian.Have eliminating pathogen in the liver gallbladder fire, the clear part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels is wet, relieving convulsion making eye bright, and the malaria protozoon is good for the stomach, the effect that protects the liver.Can treat that Liver Channel intenseness of heat, infantile convulsion are manic, encephalitis B, headache, conjunctival congestion, pharyngalgia, jaundice, hematodiarrhoea, the swollen skin infection of pain, scrotum swell and ache, pudendum pruritus due to damp pathogen, hypertension dizziness tinnitus, chest and hypochondrium, acute infectious hepatitis, cystitis, skin infection swell and ache etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 413rd page).
The present invention follows the principles of formulating prescriptions of the traditional Chinese medical science " monarch ", is monarch drug with Cornu Cervi Degelatinatum, Radix Rehmanniae Preparata, stir-baked FRUCTUS ALPINIAE OXY-PHYLLAE after sprinking salt solution and Semen Ziziphi Spinosae (parched), is ministerial drug with giving birth to Concha Margaritifera and Rhizoma Acori Graminei, is adjuvant with Radix Polygalae (processed), stir-baked SEMEN PLANTAGINIS with salt solution and wine Radix Gentianae.All medicine phases and the effect that is total to tool temperature compensation Liver and kidney, YIN nourishing and the production of body fluid promoting, the eliminating phlegm of having one's ideas straightened out, tranquillizing and allaying excitement, the treatment hyperkinetic syndrome has determined curative effect, has no side effect taking convenience, cheap characteristics.
Chinese medicine preparation of the present invention, can add the medicine acceptable carrier when being prepared into medicament, described medicine acceptable carrier can be: starch, sucrose, lactose, mannitol, silicon derivative, cellulose family and derivant thereof, alginate, gelatin, polyvinylpyrrolidone, glycerol, soil temperature 80, agar, calcium carbonate, calcium bicarbonate, surfactant, Polyethylene Glycol, cyclodextrin, beta-schardinger dextrin-, phospholipid material, Kaolin, Pulvis Talci, calcium stearate, magnesium stearate etc.
Chinese medicine preparation of the present invention can be any pharmaceutically useful dosage form, and these dosage forms comprise: tablet, sugar coated tablet, film coated tablet, enteric coated tablet, capsule, hard capsule, soft capsule, oral liquid, buccal tablet, granule, pill, powder, unguentum, sublimed preparation, suspensoid, powder, solution, injection, suppository, ointment, plaster, cream, spray, drop, patch.Preparation of the present invention, preferred Chinese medicine preparation is a peroral dosage form, as: tablet, capsule, oral liquid, buccal tablet, granule, pill, powder, suspensoid, powder, solution, drop, drop pill.Preferred Chinese medicine preparation is capsule, tablet, granule.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, the Chinese herbal medicine each component selected for use of the present invention meets the regulation of The Drug Administration Law of People's Republic of China, utilizes the comprehensive function treatment and the prevention hyperkinetic syndrome of the Chinese medicine of respectively distinguishing the flavor of, and does not have chemical sweeting agent, and is nontoxic to human body.Show that through animal acute toxicity experiment the animal of being tested does not see any toxic reaction, its main organs does not have tangible change yet, and safety of medicine is reliable.
2, the present invention need not decoct, no bitterness sense, rich in proteins in the medicine, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid, also contain various trace elements such as Saponin, plant sterol and calcium, be beneficial to absorption of human body, health invigorating, and taking convenience.
3, the present invention not only can effectively treat hyperkinetic syndrome, and the prevention of hyperkinetic syndrome is also had good effect, has improved patient's life quality greatly, and higher healing rehabilitation efficacy is arranged.
Hyperkinetic syndrome curative effect determinate standard ((the 353rd page of chief editor's " traditional Chinese medical science disease diagnosis and treatment standard and prescription are selected for use " People's Health Publisher's calendar year 2001 version such as Dai Shen)
1, cure: the class hour of lasting attention concentrated, emotion is more stable, school grade reaches the level with the age child substantially.2, take a turn for the better: action reduces, and the time of sitting quietly is longer, and attention is concentrated slightly, and school grade rises to some extent.3, do not heal: symptom and school grade do not have significant change.
Further specify the therapeutic effect of medicine of the present invention below by the clinical practice example to the treatment hyperkinetic syndrome.
As follows through clinical test results; Treatment hyperkinetic syndrome patient 39 examples, male's 28 examples, women's 11 examples, the age is 6～14 years old.Take embodiment 1 capsule, each 2-10 grain, every day three to four times, eliminating cold for resuscitation water send down, and take half an hour ante cibum.One month is a course of treatment, take continuously three the course of treatment observe the curative effect.Cure 23 examples and account for 58.9%, 12 examples that take a turn for the better account for 30.7%, and more 4 examples do not account for 10.25%, and total effective rate reaches 89.75%.After three course of therapy, patient's attention of last class hour is concentrated, and emotion is more stable, and school grade rises to some extent.And patient does not have any untoward reaction, and three big routine tests and hepatic and renal function detect no abnormal.
The specific embodiment
Embodiment 1 capsule takes by weighing raw material by following weight:
1.5 parts of 3 parts of stir-baked FRUCTUS ALPINIAE OXY-PHYLLAE after sprinking salt solution of 1 part of Radix Rehmanniae Preparata of Cornu Cervi Degelatinatum
3 parts of 1.5 parts of living Concha Margaritiferas of 1.5 parts of Rhizoma Acori Graminei of Semen Ziziphi Spinosae (parched)
1 part of 1 part of wine Radix Gentianae of 1 part of stir-baked SEMEN PLANTAGINIS with salt solution of Radix Polygalae (processed)
Preparation method is to get above-mentioned raw materials to decoct with water twice, 1.5～2 hours for the first time, and 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, reclaim ethanol, when spending, 50 degree～55 are concentrated into the clear paste of relative density 1.30～1.32, drying is ground into fine powder, incapsulates.Adorn 0.3 gram for every, usually half an hour ante cibum oral, eliminating cold for resuscitation water send down, one time 2～10, three to four times on the one, one month is a course of treatment.
Embodiment 2 tablets take by weighing raw material by following weight:
1.5 parts of 3 parts of stir-baked FRUCTUS ALPINIAE OXY-PHYLLAE after sprinking salt solution of 1 part of Radix Rehmanniae Preparata of Cornu Cervi Degelatinatum
3 parts of 1.5 parts of living Concha Margaritiferas of 1.5 parts of Rhizoma Acori Graminei of Semen Ziziphi Spinosae (parched)
1 part of 1 part of wine Radix Gentianae of 1 part of stir-baked SEMEN PLANTAGINIS with salt solution of Radix Polygalae (processed)
Preparation method is to get above-mentioned raw materials to decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, reclaim ethanol, when spending, 50 degree～55 are concentrated into the clear paste of relative density 1.30～1.32, drying is ground into fine powder, adds appropriate amount of starch, alcohol granulation, after the drying, add an amount of magnesium stearate, tabletting, sugar coating are promptly.Usually half an hour ante cibum oral, eliminating cold for resuscitation water send down, one time 2～10, three to four times on the one, one month is a course of treatment.
Embodiment 3 granules take by weighing raw material by following weight:
1.5 parts of 3 parts of stir-baked FRUCTUS ALPINIAE OXY-PHYLLAE after sprinking salt solution of 1 part of Radix Rehmanniae Preparata of Cornu Cervi Degelatinatum
3 parts of 1.5 parts of living Concha Margaritiferas of 1.5 parts of Rhizoma Acori Graminei of Semen Ziziphi Spinosae (parched)
1 part of 1 part of wine Radix Gentianae of 1 part of stir-baked SEMEN PLANTAGINIS with salt solution of Radix Polygalae (processed)
Preparation method is to get above-mentioned raw materials to decoct with water twice, 1.5～2 hours for the first time, and 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10 adds ethanol and makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, reclaim ethanol, when 50 degree～55 are spent, be concentrated into the clear paste of relative density 1.30～1.32, drying, be ground into fine powder, add an amount of sucrose and soluble starch, alcohol granulation, the pack of dry back is promptly.Usually half an hour ante cibum warm boiled water, one time 1～3 bag, three to four times on the one, one month is a course of treatment.
Claims (6)
1, a kind of Chinese medicine preparation for the treatment of hyperkinetic syndrome is characterized in that it is made by the following weight proportion raw material:
0.5～3.0 part of 1.5～6.0 parts of stir-baked FRUCTUS ALPINIAE OXY-PHYLLAE after sprinking salt solution of 0.1～2.0 part of Radix Rehmanniae Preparata of Cornu Cervi Degelatinatum
1.5～6.0 parts of 0.5～3.0 part of living Concha Margaritiferas of 0.5～3.0 part of Rhizoma Acori Graminei of Semen Ziziphi Spinosae (parched)
0.1～2.0 part of 0.1～2.0 part of wine Radix Gentianae of 0.1～2.0 part of stir-baked SEMEN PLANTAGINIS with salt solution of Radix Polygalae (processed)
2, a kind of Chinese medicine preparation for the treatment of hyperkinetic syndrome according to claim 1, wherein the weight proportion of each raw material is:
1.0～2.0 parts of 2.5～3.5 parts of stir-baked FRUCTUS ALPINIAE OXY-PHYLLAE after sprinking salt solution of 0.5～1.5 part of Radix Rehmanniae Preparata of Cornu Cervi Degelatinatum
2.5～3.5 parts of 1.0～2.0 parts of living Concha Margaritiferas of 1.0～2.0 parts of Rhizoma Acori Graminei of Semen Ziziphi Spinosae (parched)
0.5～1.5 part of 0.5～1.5 part of wine Radix Gentianae of 0.5～1.5 part of stir-baked SEMEN PLANTAGINIS with salt solution of Radix Polygalae (processed)
3, a kind of Chinese medicine preparation for the treatment of hyperkinetic syndrome according to claim 1, wherein the weight proportion of each raw material is:
1.5 parts of 3 parts of stir-baked FRUCTUS ALPINIAE OXY-PHYLLAE after sprinking salt solution of 1 part of Radix Rehmanniae Preparata of Cornu Cervi Degelatinatum
3 parts of 1.5 parts of living Concha Margaritiferas of 1.5 parts of Rhizoma Acori Graminei of Semen Ziziphi Spinosae (parched)
1 part of 1 part of wine Radix Gentianae of 1 part of stir-baked SEMEN PLANTAGINIS with salt solution of Radix Polygalae (processed)
4, the Chinese medicine preparation of claim 1-3 is to be fit to medicinal various dosage forms.
5, the Chinese medicine preparation of claim 4 is tablet, capsule, oral liquid, buccal tablet, granule, pill, powder, suspensoid, powder, solution, drop, drop pill.
6, the Chinese medicine preparation of claim 4 is capsule, tablet, granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101145450A CN100450532C (en) | 2006-11-15 | 2006-11-15 | Chinese medicinal formulation for treating children's hyperkinetic syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101145450A CN100450532C (en) | 2006-11-15 | 2006-11-15 | Chinese medicinal formulation for treating children's hyperkinetic syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1966035A true CN1966035A (en) | 2007-05-23 |
| CN100450532C CN100450532C (en) | 2009-01-14 |
Family
ID=38075128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006101145450A Expired - Fee Related CN100450532C (en) | 2006-11-15 | 2006-11-15 | Chinese medicinal formulation for treating children's hyperkinetic syndrome |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100450532C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102205032A (en) * | 2011-05-31 | 2011-10-05 | 山东省农业科学院农产品研究所 | Golden mushroom oral liquid for treating hyperactivity disease |
| CN103611039A (en) * | 2013-12-05 | 2014-03-05 | 侯青兰 | Medicament for treating attention deficit hyperactivity disorder and preparation method thereof |
| CN104224975A (en) * | 2014-08-23 | 2014-12-24 | 布焕景 | Traditional Chinese medicinal composition for treating phlegm stagnation type attention deficit hyperactivity disorder and application thereof |
-
2006
- 2006-11-15 CN CNB2006101145450A patent/CN100450532C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102205032A (en) * | 2011-05-31 | 2011-10-05 | 山东省农业科学院农产品研究所 | Golden mushroom oral liquid for treating hyperactivity disease |
| CN102205032B (en) * | 2011-05-31 | 2012-07-25 | 山东省农业科学院农产品研究所 | Golden mushroom oral liquid for treating hyperactivity disease |
| CN103611039A (en) * | 2013-12-05 | 2014-03-05 | 侯青兰 | Medicament for treating attention deficit hyperactivity disorder and preparation method thereof |
| CN103611039B (en) * | 2013-12-05 | 2015-07-08 | 侯青兰 | Medicament for treating attention deficit hyperactivity disorder and preparation method thereof |
| CN104224975A (en) * | 2014-08-23 | 2014-12-24 | 布焕景 | Traditional Chinese medicinal composition for treating phlegm stagnation type attention deficit hyperactivity disorder and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100450532C (en) | 2009-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100473413C (en) | Chinese medicine preparation for treating senile dementia | |
| CN107126485A (en) | It is a kind of to aid in improving Chinese medicine composition of sleep and its preparation method and application | |
| CN101028376A (en) | Chinese medicinal preparation for treating habitual abortion | |
| CN100431593C (en) | Chinese medicinal formulation for treating hydrocephalus | |
| CN100450532C (en) | Chinese medicinal formulation for treating children's hyperkinetic syndrome | |
| CN104338050A (en) | Health care product capable of improving sleep quality | |
| US20230125425A1 (en) | Traditional chinese medicine extract composition with function of regulating depressive emotion and preparation method and traditional chinese medicine preparation thereof | |
| CN104524247B (en) | One treats migrainous medical composition and its use | |
| CN100450531C (en) | Chinese medicinal formulation for treating infant bed wetting | |
| CN101028490A (en) | Chinese medicine for treating acne | |
| CN100431584C (en) | Chinese medicinal formulation for caring and enlarging breast | |
| CN100408048C (en) | Capsule for treating rheumatism and rheumatoid diseases and scapulohumeral periarthritis and preparation method thereof | |
| CN1958028A (en) | Preparation of Chinese traditional medicine for treating hyperplasia of prostate | |
| CN1943766A (en) | A Chinese traditional medicinal preparation for treatment of psoriasis | |
| CN100571749C (en) | A kind of Chinese medicine preparation for the treatment of sexual impotence | |
| CN102671052B (en) | Chinese medicinal composition for treating Meniere's syndrome | |
| CN100571743C (en) | A kind of Chinese medicine preparation for the treatment of sexual impotence | |
| CN101028362A (en) | Chinese medicine for treating leucoderma | |
| CN101045145A (en) | Health-care food for improving sexual function | |
| CN105749103A (en) | Pharmaceutical preparation for treating narcolepsy and preparation method thereof | |
| CN103356984B (en) | Traditional Chinese medicine composition for preventing and treating female iron deficiency anemia | |
| CN101032576A (en) | Impotence-treating Chinese traditional medicine prepn. and its prepn. process | |
| CN1931340A (en) | Leukoderma treating Chinese medicine prepn | |
| CN100571730C (en) | A kind of Chinese patent medicine for the treatment of sexual impotence | |
| CN101019988A (en) | Diabetes treating Chinese medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING WAN SHOU TONG PHARMACEUTICAL TECHNOLOGY C Free format text: FORMER OWNER: WANG XINSUO Effective date: 20080822 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20080822 Address after: Room 230 (Park), No. 19 West Fourth Ring Road South, Beijing, Fengtai District, China: 100072 Applicant after: Beijing Wanshoutong Pharmaceutical Technology Corp. Address before: Beijing Fengtai Changxindian Hospital postal code: 100078 Applicant before: Wang Xinsuo |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090114 Termination date: 20101115 |